Navigation Links
Joseph Perrone Joins SRI International to Direct Molecular Diagnostics and Rare and Neglected Diseases Group
Date:11/11/2010

MENLO PARK, Calif., Nov. 11, 2010 /PRNewswire/ -- SRI International, an independent nonprofit research and development organization, announced today that Joseph Perrone, Sc.D., has joined SRI International's Center for Advanced Drug Research (CADRE) in Shenandoah Valley, Virginia. In his new role, Dr. Perrone will head CADRE's molecular diagnostic efforts, including its rare and neglected diseases program.

Dr. Perrone is an experienced marketing and business development executive who has led global teams and developed successful strategic alliances. His leadership guided a team to develop pioneering instrumentation and rapid diagnostic tests for infectious and tropical diseases. Additionally, Dr. Perrone opened new markets and developed a profitable international business throughout Africa, Asia, Latin America and Europe.

"Joe Perrone is an accomplished manager, with exceptional ability to work closely with public health programs and bridge the gap between marketing and scientific challenges," said Krishna Kodukula, Ph.D., CADRE executive director. "His results-oriented approach and significant experience building creative and innovative teams will be an asset to SRI."

Prior to joining SRI, Dr. Perrone served as president of JBP Consulting. His past experience includes serving as Vice President of Strategic Initiatives and Business Development at the American Association for Clinical Chemistry and Vice President of Standards, Certification, and Product Development at American Type Culture Collection.

Earlier, he was Vice President of the Technology Transfer Office at the University of Maryland Biotechnology Institute. Dr. Perrone previously served as the Director of Business Development and R&D Team Manager at Becton Dickinson, where he was responsible for the rapid manual test business, technology assessment, and clinical trials in international markets.

Dr. Perrone received his Sc.D. from Johns Hopkins University and completed a postdoctoral fellowship at Harvard University. He has served as an advisor to the World Health Organization (WHO) and on the WHO diagnostic steering committee. He has received numerous marketing awards, including the R&D 100 award. Dr. Perrone has also served on the boards of FASGen and Legacy Direct, and is an advisor to Instantlabs.

About SRI's Center for Advanced Drug Research (CADRE)

SRI established the Center for Advanced Drug Research (CADRE) to improve the productivity of the pharmaceutical industry, help our nation respond to biothreats, and develop life-saving treatments for rare and neglected diseases. CADRE's mission is to create new therapeutics, diagnostics, and vaccines for infectious and other diseases and for biodefense. CADRE combines and partners with SRI's well-established expertise in drug discovery, computational biology, and preclinical development with a new proteomics laboratory to develop these solutions.

About SRI's Biosciences Division

SRI's Biosciences division carries out basic research, drug discovery, and drug development, and provides contract (CRO) services. SRI has all of the resources necessary to take R&D from "Idea to IND"®—from initial discovery to the start of human clinical trials—and specializes in cancer, immunology and inflammation, infectious disease, and neuroscience. SRI's product pipeline has yielded marketed drugs, therapeutics currently in clinical trials, and additional programs in earlier stages. In its CRO business, SRI has helped government and commercial clients and partners advance many drugs into patient testing. SRI is also working to create the next generation of technologies in areas such as diagnostics, drug delivery, medical devices, and systems biology.

About SRI International

Silicon Valley-based SRI International is one of the world's leading independent research and technology development organizations. SRI, which was founded by Stanford University as Stanford Research Institute in 1946 and became independent in 1970, has been meeting the strategic needs of clients and partners for more than 60 years. Perhaps best known for its invention of the computer mouse and interactive computing, SRI has also been responsible for major advances in networking and communications, robotics, drug discovery and development, advanced materials, atmospheric research, education research, economic development, national security, and more. The nonprofit institute performs sponsored research and development for government agencies, businesses, and foundations. SRI also licenses its technologies, forms strategic alliances, and creates spin-off companies. In 2009, SRI's consolidated revenues, including its wholly owned for-profit subsidiary, Sarnoff Corporation, were approximately $470 million. Sarnoff Corporation, a leader in vision, video, and semiconductor innovations, will be fully integrated into SRI effective January 1, 2011.


'/>"/>
SOURCE SRI International
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Saint Josephs Hospital First in Georgia to Offer Noninvasive Treatment of Brain Disorders with Leksell Gamma Knife Perfexion
2. Speedus Engages Morgan Joseph to Evaluate Strategic Alternatives for Zargis Subsidiary
3. Dr. John Mills and Joseph Gentile Join Board of Directors of ChanTest Corporation
4. PDI Mourns Death of Board Member Dr. Joseph T. Curti
5. Liberator Medical Strengthens its Board of Directors with the Addition of Mr. Joseph Farish and Mr. Robert S. Cuillo
6. The Womens Heart Foundation Presents the Womens Heart Advocate Award for Medicine and Science to Multifunction CardioGram(TM) Inventor Dr. Joseph T. Shen
7. MoleSafe USA Expands Services to Leading Cancer Facilities at St. Josephs/Candler and CentraState Medical Center
8. Alexza Pharmaceuticals Appoints Joseph L. Turner to Its Board of Directors
9. Regenicin Appoints Amgen Co-founder Dr. Joseph Rubinfeld to Board of Directors
10. Joseph J. LaRosa Joins Nycomed US Inc.
11. General Wesley Clark Joins Immtech as Consulting Strategic Advisor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... PHILADELPHIA , Oct. 2, 2017 Halo Labs announces ... particle analysis system called the HORIZON at MIBio 2017 in ... analyzes subvisible and visible particulate matter in biopharmaceutical samples with unprecedented ... use of the novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
(Date:9/27/2017)... Sept. 27, 2017  Commended for their devotion to personalized ... Ranked as number one in the South Florida Business Journal,s ... Inc. 5000 yearly list, the national specialty pharmacy has found ... Bardisa will soon be honored by SFBJ as the ... Set to receive his award in October, Bardisa ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional women, ... towards gender equality at their inaugural Summit in New York City in June. The ... social audience of over 3 million. To watch the Mobilize Women video, click ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader ... been awarded a contract by the Center for Medicare and Medicaid Services (CMS). ... the enterprise use of Agile methodologies in a consistent and high value manner ...
(Date:10/12/2017)... San Francisco, CA (PRWEB) , ... October 12, ... ... and Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus ... sleep apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... The American ... Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium ... 8. , In honor of Morris F. Collen, a pioneer in the field of ...
(Date:10/12/2017)... PA (PRWEB) , ... October 12, 2017 , ... ... is the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B ... York City on October 11, 2017. , The annual award competition recognizes editorial and ...
Breaking Medicine News(10 mins):